Bank of Nova Scotia’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bank of Nova Scotia’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-348,512	Closed	-$57.6M	–	1233
2021 Q2	$57.6M	Buy	348,512 +297,558	+584%	+$49.7M	0.11%	174
2021 Q1	$7.81M	Buy	+50,954	New	+$6.92M	0.02%	462
2020 Q4	–	Sell	-151,641	Closed	-$15.4M	–	1089
2020 Q3	$15.4M	Buy	151,641 +74,274	+96%	+$7.57M	0.04%	288
2020 Q2	$7.53M	Buy	+77,367	New	+$7.2M	0.03%	349
2020 Q1	–	Sell	-35,892	Closed	-$3.99M	–	994
2019 Q4	$3.99M	Buy	+35,892	New	+$3.69M	0.01%	563
2017 Q2	–	Sell	-100,000	Closed	-$6.52M	–	1011
2017 Q1	$6.52M	Buy	+100,000	New	+$5.89M	0.03%	352

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Bank of Nova Scotia's PRAH Position: Q3 2021 in Review

Bank of Nova Scotia sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 348,512 shares — an estimated $57.6M sold.

Bank of Nova Scotia first reported a position in PRAH in Q1 2017 and held it in 6 quarters. The position peaked at $57.6M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Bank of Nova Scotia reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Bank of Nova Scotia sold 348,512 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $57.6M.
Bank of Nova Scotia first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 6 quarters.
Bank of Nova Scotia's PRA Health Sciences, Inc. position peaked at $57.6M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Bank of Nova Scotia's 13F filing for Q3 2021, filed 12 Nov 2021.